Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Common Equity (2020 - 2025)

Historic Common Equity for Core Scientific (CORZ) over the last 6 years, with Q3 2025 value amounting to -$1.1 billion.

  • Core Scientific's Common Equity fell 5464.22% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year decrease of 5464.22%. This contributed to the annual value of -$820.2 million for FY2024, which is 3739.72% down from last year.
  • Latest data reveals that Core Scientific reported Common Equity of -$1.1 billion as of Q3 2025, which was down 5464.22% from -$1.1 billion recorded in Q2 2025.
  • In the past 5 years, Core Scientific's Common Equity ranged from a high of $1.3 billion in Q4 2021 and a low of -$1.1 billion during Q3 2025
  • Its 5-year average for Common Equity is -$241.1 million, with a median of -$392.4 million in 2023.
  • Per our database at Business Quant, Core Scientific's Common Equity surged by 918626986.3% in 2021 and then crashed by 67338.52% in 2023.
  • Quarter analysis of 5 years shows Core Scientific's Common Equity stood at $1.3 billion in 2021, then crashed by 130.52% to -$409.3 million in 2022, then crashed by 45.83% to -$596.9 million in 2023, then tumbled by 37.4% to -$820.2 million in 2024, then crashed by 37.53% to -$1.1 billion in 2025.
  • Its Common Equity stands at -$1.1 billion for Q3 2025, versus -$1.1 billion for Q2 2025 and -$181.5 million for Q1 2025.